HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).

Attendees

Please include your organization in your Zoom name.

• Click on your picture/name in Zoom
• Click on rename
• enter <name> - <organization>

Agenda Items and Notes

Outstanding Action Item List

Meeting Notes from previous meeting

• 2023-02-13 Meeting Notes  - Accepted by general consent

Project Proposals

Project Proposals in Review - 

PSS-2155 Adverse Event Clinical Research Implementation Guide - no Pharmacy interest at this time

PSS-2149 AI Data Lifecycle - no Pharmacy interest at this time

Project Scope Statements

Project Scope Statements - NONE to review

May WGM Draft Agenda Review

External Meeting Review

Catalog Updates (John Hatem)

• 27 Feb 2023 - No meeting last week

Workflow Update (John Hatem)

• 27 Feb 2023  - Tracker discussions - Definition Pattern - no Pharmacy impact

Healthcare Product Update (John Hatem)

• 27 Feb 2023 - Tracker discussions - no Pharmacy impact

EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem / Jimmy Tcheng)

• 27 Feb 2023- next meeting is in the first week of March

Project updates

Pharmacy Templates

• 27 Feb 2023 - no updated today

Trackers - Pharmacy Tracker Dashboard (see trackers for details / resolutions)

• Scott M. Robertson will review to make sure the 2 assigned to him are ready to discuss/vote next week

• FHIR-36499 - Getting issue details... STATUS Motion: Scott Robertson/Margaret Weiker  vote: 7-0-0
• FHIR-37948 - Getting issue details... STATUS - Technical correction - no vote required
• FHIR-39631 - Motion: Jose Costa Teixeira/Joe Kelly 7-0-0
• Report from Jean Duteau - we are on track with our trackers being updated for R5

Status state diagram review 

• John reviewed the mapping between Med dispense status and BDP dispense status.  Suggestion was to send this to the list serve for input. 
  • 13 Feb 2023 review of mapping document.  
    
    • "ready for pickup" (in pharmacy) compares to "allocated" in BDP.
      • BDP "allocated" description is "ready for transport"   
    • "returned" - we don't have it, do we need it (returned after picked up).  usually these are wasted ... but can be reused in some cases. 
      • as opposed to "return to stock," which was "ready for pickup" and not received by patient.
    • pharmacy "completed" - BDP says "issued"
    • pharmacy "stopped" ("failed") - BDP uses "unfulfilled".
    • pharmacy "declined" ("not-done) - maybe BDP "returned" ("abandoned")
  • 27 Feb 2023 - no report this week

Timing questions (Jose)

27 Feb 2023 - 

• FHIR-40440 - Getting issue details... STATUS - new tracker was created to add a table of examples into this datatype. 

NCPDP Updates (NCPDP Members)

27 Feb 2023 - No updates this week

Pharmacist Consult Note (Scott)

• 27 Feb 2023 - Publication Request
  • OTHER-2672 - Getting issue details... STATUS
  • 20230226 Pharmacist Consultation Note for publication.docx
  • Publication Request - Pharmacist Consultation Note update
  • Scott reported on the Pub Request.  Motion to accept Pub Request: Scott Robertson/Margaret Weiker 7-0-0

Specialty Medication Enrolment IG

• 27 Feb 2023 - no report

Any Other Business

Next meeting:

• 06 Mar 2023